Context: Osteogenesis imperfecta (OI) is associated with reduced muscle size, dynamic muscle function, and mobility.
(BP) therapy in children with OI increases bone mass (6) by inhibiting bone resorption, but evidence of fracture reduction remains limited (7) . To date, there is a complete lack of anabolic therapy to directly target the impaired bone formation and muscle function in OI.
Whole body vibration (WBV) training (high frequency, low or variable magnitude, using a vibrating platform) is widely used to improve physical fitness (8, 9) . Several small randomized controlled trials and observational studies in children with cerebral palsy (10) (11) (12) (13) (14) (15) (16) (17) and other pediatric disabling conditions (12, (18) (19) (20) (21) have demonstrated a beneficial effect of WBV on walking speed, muscle strength, spasticity, and balance. The underlying concept of mechanical stimulation to bone is the mechanostat theory (22) , which states that bone adapts its strength to mechanical forces that are mostly imposed by muscle. Accordingly, any treatment that strengthens muscle should lead to improvements in bone structure and mass, mobility, balance, and risk of fall. Of note, bone formation increases significantly and in excess of bone resorption after short-term use of WBV in healthy children (23) .
Using WBV therapy as an adjunctive therapy in children with OI and limited mobility is therefore tempting, especially because substantial improvements in cortical thickness of femora and tibiae, and higher trabecular tibial bone volume have been reported following WBV in a mouse model of OI (24) . In addition, data from an uncontrolled observational study in 53 children with OI treated with WBV within an intensive rehabilitation program showed increased muscle strength and mobility (25, 26) . To date, there are no randomized controlled studies using WBV in children or adults with OI.
This paired randomized controlled pilot trial aimed to assess the effect of 5-months of WBV training on bone mass, geometry, and density, as well as muscle function and size, mobility, and balance in children with OI.
Subjects and Methods
Between May 2012 and May 2015, 24 children (5 to 16 years) with clinically mild to moderate OI (Sillence types 1, 4) with limited mobility were recruited from OI specialist clinics at tertiary Children's Hospitals in Birmingham, Sheffield, and Manchester, as well as through an advertisement placed on the Brittle Bone Society Web site. Limited mobility was defined by a Child Health Assessment Questionnaire (CHAQ) score of $0.13 (27) , with the minimum ability to rise from a chair.
BP therapy increases mobility and isometric grip force during the first treatment years (28, 29) . In order not to confuse such secondary improvements in muscle function due to BP therapy with primary effects from WBV, children had to be either naive to BP therapy, or had to have received BP therapy for more than 2 years (current therapy), or stopped BP therapy at least 6 months prior to enrollment (previous therapy). Children were excluded if they had experienced a lower limb fracture within 3 months of enrollment, or a recent upper limb fracture still in plaster, if they had heart or lung disease, or if on steroid therapy (oral, systemic, topical, or inhaled, for more than 3 weeks in the last 12 months) or any other bone-active treatment. The study design required children to be recruited in pairs matched for sex and pubertal stage group [prepubertal (Tanner stage 1), pubertal (Tanner stage 2 to 4), postpubertal (Tanner stage 5)]. Eligible pairs of children were invited to attend the Wellcome Trust Clinical Research Facility at Birmingham Children's Hospital, where informed consent was taken from the participant and their parent or guardian, and all study investigations took place. Specific history recorded included details of medication, duration, dose, and frequency of previous/current BP therapy, recent medical history, fracture, and rodding surgery. Pairs of children were then randomized so that one received 5 months of twice-daily vibration training (n = 12) and the other regular care (n = 12), using sealed envelopes. This registered trial (NCT03029312) complied with the ethical principles for medical research set by the Declaration of Helsinki and was approved by the regional ethics committee.
Outcome measures
The following outcome measures were taken in both groups before and following the 5-month intervention.
Anthropometry and incident fractures
Height and weight were measured using a Harpenden Stadiometer and electronic scales, respectively, wearing light indoor clothing. Pubertal stages were assessed according to Tanner (30) , either by physical examination or through selfrating using standard graphical illustrations. Body mass index (BMI) was calculated as kg/m 2 . Sex-and age-specific z scores for height, weight, and BMI were calculated according to UK reference data (31, 32) . Location and nature of radiographically confirmed incident fractures during the study were recorded.
Dual-energy X-ray absorptiometry
Dual-energy X-ray absorptiometry (DXA) scans of the lumbar spine, hip, and total body were performed on a Lunar iDXA (GE, Madison, WI). Size corrections included calculation of bone mineral apparent density (BMAD) at the lumbar spine (33) and removing the head from the total body scan (TBLH) (34) . Hip scans are reported for the right, or nonrodded, femoral neck and hip. Bone mineral density (BMD) results are presented as z scores for age. Lumbar spine z scores were generated from our large local cohort of 1500 healthy children (35) . Hip and TBLH z scores, lean mass for height z scores, and percent body fat were derived from the manufacturer's database. Leg bone mass and leg lean mass were derived from the total body scan.
Peripheral quantitative computed tomography
A peripheral quantitative computed tomography (pQCT) scan of the tibia using a Stratec XCT2000 scanner (Stratec Medizintechnik, Pforzheim, Germany) was performed at the distal (4% of tibia length) and proximal tibia (66% of tibia length). Outcome measures included trabecular and total bone densities at the 4% site, and cortical density, bone and muscle cross sectional areas, muscle density, and estimated cortical thickness at the 66% site. Reproducibility of tibia bone and muscle pQCT parameters has been described previously (36, 37) .
Mobility, muscle function, and balance CHAQ. The CHAQ score is a common tool to measure mobility/disability in children, assessing various motor function skills involved in dressing, arising, eating, walking, hygiene, reach, and grip (27) . The possible score range is 0 to 3, with limited mobility defined as a score $0.13. Pain was assessed separately using a faces pain scale (38) .
Six-minute walk test. The 6-minute walk test is a standardized endurance test where children are asked to walk as far as possible over 6 minutes. The maximum distance covered during this 6-minute walk (6MWD) in 30-m laps with cones at the turning points was measured, using standardized encouragement (39) . Sex-specific z scores for age and height were calculated as previously reported (40) .
Mechanography. Dynamic muscle function was assessed using a Leonardo™ Mechanograph Ground Reaction Force Plate (Novotec Medical, Inc, Pforzheim, Germany) (41) with proprietary software. The following tests were performed using standard procedures, with best of three repetitions retained (42, 43) : (1) single two-legged jump, a vertical countermovement jump to achieve maximum jumping height; (2) multiple onelegged hopping on the dominant forefoot (like rope-skipping) to achieve maximal vertical ground reaction forces during eccentric muscle contraction; (3) chair rise test (five sit-to-stand repetitions); and (4) heel rise test (five bilateral heel rises with knees kept stiff) with the aim to achieve maximal speed during the upward movement. High reproducibility of all muscle forcetime data reported here has been recently described (43) .
Outcome variables were (1) peak power per body weight (W/kg), peak force per body weight (N/kg being dimensionless), peak velocity (m/s), and jumping height (m) during eccentric muscle contraction for the single two-legged jump, (2) peak force for the multiple one-legged hop, and (3+4) mean time per repetition (s) and peak power in the rising phase (W/kg) in the chair and heel rise tests. Peak ground reaction force per body weight measured in multiple one-legged hopping is considered the most appropriate variable for assessing the muscle-bone unit at the tibia in children, as bone is expected to adapt to the peak forces (44) .
This device also measures balance (swaying area), and manufacturer's instructions were followed. Depending on their individual ability, participants were asked to stand for 10 seconds, (1) on one foot, (2) on two feet in tandem stand, (3) in semitandem stand, and (4) in parallel feet stand. Categories 1 to 4 reflect decreasing balance abilities. Both decreasing balance category, and decreasing swaying area, reflect improvement.
Intervention
Children randomized to "regular care" (controls) continued to receive routine care including physiotherapy. Children randomized to "vibration" had their first WBV training sessions under supervision in the Wellcome Trust Clinical Research Facility at Birmingham Children's Hospital and were subsequently supplied with a vibration device (Galileo M™, Novotec Medical, Inc) for home use. Vibration training was supervised by a research physiotherapist (J.S.) and included several scheduled home visits to ensure correct, individualized training and adherence. Children were asked to keep a training record, and the device recorded adherence data (date, time, frequency, and duration of use).
The Galileo M™ device has a motorized board that produces side-to-side alternating vertical sinusoidal (rotational) vibrations around a fulcrum in the midsection of the plate. The vibration frequency can be selected by the user who stands on the board with both feet, wearing shoes. The peak-to-peak displacement to which the feet are exposed increases with the distance of the feet from the center line of the vibrating board. Three positions marked 1, 2, and 3 are indicated on the vibrating board, corresponding to peak-to-peak displacements of 2, 4, and 6 mm. The peak acceleration exerted by vibration exercise increases with higher frequencies and higher amplitudes.
Children used the device twice daily for 3 3 3 minutes, with 3-minute breaks (total active training time daily 18 minutes) for 5 months. Children were asked to stand upright on the platform, with knees bent (10 to 45 degrees, semisquat or squat position). A schedule of increasing intensity of vibration exercise was used over time, allowing some adjustment to the patient's physical capability. Amplitude 1 was used for the first 2 weeks, then increased to amplitude 2 and further increased up to amplitude 3, if individually possible, always using frequencies between 20 and 25 Hz. Children were also asked to perform exercises on the platform, including shifting their weight from one side to the other or increase/decrease their knee and hip angle. Other exercise included weight shift with rotation of the trunk, and alternate flexion and extension of knees. Where possible, active squats or semisquats were done on the platform.
The safety of vertical and rotational WBV treatment regimens have been demonstrated in previous studies in children with disability (10) (11) (12) (13) (14) (15) (16) (17) and OI (25, 26) . In all pediatric and adult studies, vibration treatment was well tolerated, including children with OI carrying intramedullary rods. Because forces produced during WBV therapy are lower compared with forces applied during walking and running in daily life (45) (46) (47) , and participants were at least partially ambulant, WBV was not considered a safety risk. Nevertheless, children were asked to report any discomfort, fatigue, or pain.
Statistical analysis
In the absence of pilot data for OI children, the primary end point variable chosen for sample size calculation was total tibial volumetric BMD at the tibial 4% site, measured by pQCT, guided by a pilot WBV study in disabled children, accepting their use of different vibration and scanning technology (12) .
Matching by sex and pubertal stage was done to optimize comparability of results. Randomization allocated one of each pair to vibration or no vibration. All outcome variables were tested for normal distribution and, given the small sample sizes, descriptive statistics are presented as median (range). To describe the extent of disease and immobility, baseline data were compared against reference data from healthy children (zero) for anthropometry (31, 32) , DXA (35) , and dynamic muscle function [single two-leg jumps, multiple one-leg hops (42) , and chair rise test (48) ] using one-sample t tests. Spearman correlation was used to assess associations among variables at baseline.
Study results are reported according to the standards set by the International Society of Musculoskeletal and Neuronal Interactions (49) . The 5-month change in absolute values and z scores in all outcome variables in the vibration group was compared with those of the control group using Wilcoxon signed rank test, or paired t test, as appropriate. All tests were two-tailed and throughout the study P , 0.05 was considered significant. Calculations were performed using SPSS Statistics for Windows, version 22.0 (IBM Corp, Armonk, NY) by a qualified biostatistician (P.N.).
Results

Baseline characteristics
Twenty-four children (12 pairs, matched by sex and pubertal stage) were recruited into the study. Their baseline characteristics are shown in Table 1 . As expected, the total group of OI children were shorter (P , 0.001) compared with the reference population (zero). The vibration group had slightly greater BMI z scores and percent body fat compared with the control group. The total group's limited mobility was demonstrated by their median (range) CHAQ score of 1.187 (0.375 to 1.875) and low 6MWD z scores for age [22.34 (26.51 to 20.58); P , 0.001] and height [21.49 (25. 60 to 0.82); P , 0.001], with no significant differences between the vibration and control groups. Similarly, dynamic muscle function variables of the total cohort were significantly lower in all patients compared with the reference population (P # 0.001), with no difference between the two groups. Figure 1 demonstrates the effect of body mass on mobility. BMI z score correlated positively with CHAQ scores (r = 0.552, P = 0.005) and negatively with 6MWD z scores (r = 20.405, P = 0.049), weight-related, twolegged peak jumping power (r = 20.557, P = 0.007), velocity (r = 20.654, P = 0.001), and jumping height (r = 20.585, P = 0.004). Very similar significant relationships of these functional variables were observed with percent body fat, but not with lean mass/height z score (data not shown).
Response to 5 months of vibration therapy
Two prepubertal, male pairs had to be excluded because two boys randomized to WBV, both previously treated with BP, dropped out of the study due to incident fractures. One boy had a suspected leg fracture after consent and before starting WBV therapy, which delayed the start of therapy. He later suffered an atraumatic pelvic fracture toward the end of the 5-month intervention. The other boy sustained a left fibula fracture and experienced intermittent pain in his right tibia during WBV training from a pre-existing mal-positioned rod. None of these fractures occurred during a WBV training session. In both cases, prolonged rehabilitation did not allow regular use of the device and caused an unacceptably long delay to the postintervention visits, leading to secondary exclusion. Of note, their 6MWD (age z scores 26.14; 26.51) and peak two-legged jumping force (z scores 25.04; 25.10) at baseline were the lowest, by far, of the entire cohort with no apparent difference in bone mass.
The remaining 10 pairs therefore consisted of four male pairs (three prepubertal, one postpubertal) and six female pairs (five prepubertal, one postpubertal), including a pair of identical twins. Five children each in the vibration and control groups, had previous or current BP therapy for more than 2 years, and five children each Figure 1 . Baseline correlations between BMI z scores of 24 children with OI with their CHAQ score, 6MWD (z scores for age and height), and weight-related peak power, velocity, and jumping height in the single two-legged jump (S2LJ).
were naive to BP therapy. Median (range) adherence to WBV was 84% (63% to 96%), with recorded average frequency of 24.1 Hz (23.2 to 24.5), and highest amplitudes between 2 and 3.
There were no significant differences between the vibration and control group in the 5-month changes in growth, bone density, or geometry ( Table 2 ). The vibration group had a significantly greater increase in total lean mass [+1119 g (224 to +1744)] over 5 months compared with controls [+635 g (2951 to +1006)], P = 0.01, and a corresponding change in lean mass/height z score. Similar changes were observed in other muscle variables, such as leg lean mass and cross-sectional muscle area at the 66% site, but these did not reach statistical significance (Fig. 2) . However, the increase in lean mass was not associated with substantive improvements in mobility or dynamic muscle function, as measured by CHAQ, 6-minute walk test, and mechanography (Table 3 ). There was no significant difference between the two groups in variables of balance (data not shown). Adjustment for previous or current BP therapy did not alter the results. The results of the entire study population were reflected in those of the identical twin pair (both on BP therapy, data not shown).
In addition to the low impact fractures that had led to exclusion of two boys, one child sustained an accidental nose fracture and another one a finger fracture in the WBV group during the study period (unrelated to WBV training sessions). There were no fractures in the control group, apart from one child who had incidental vertebral fractures detected during the study.
Discussion
This randomized controlled study in children with OI demonstrated no effect of 5-month, twice-daily rotational WBV on bone mass, density, or geometry despite a significant increase in total lean mass. Muscle mass or size are often used as surrogates for muscle force in able-bodied children. This study in children with OI indicates that increments in lean mass are not necessarily associated with improvements in mobility, 6MWD, dynamic muscle function, or balance. In line with the recent observation that children with OI produce less peak force per muscle size (2), our results suggest reduced biomechanical responsiveness of their muscle-bone unit. Together with the potential safety concern that substantial incident fractures occurred in the two muscularly weakest children only in the WBV group, our results do not encourage the use of WBV in OI children.
Vibration training (whether vertical or rotational) is designed to improve peak muscle forces, and secondary effects on bone are expected according to the mechanostat theory (22) . The fairly large number of randomized studies demonstrating positive effects of WBV on walking speed, muscle strength, spasticity, and balance in children with cerebral palsy (10) (11) (12) (13) (14) (15) 17) or other disabilities (12, 19) , indicate that this treatment modality appears efficacious and safe in children without a primary bone formation defect. Therefore, the results of this study raise several questions. Our results are in contrast with evidence from a murine model of OI, where 5 weeks of vertical WBV increased cortical thickness of femur and tibia (24) , and to some extent from an observational study in children with a wide range of OI severity, which suggested rotational WBV improves motor function and walking distance (25, 26) . The lack of a bone effect despite improved total lean mass in this study questions whether OI bone may respond less to vibration therapy compared with non-OI bone. Such decreased responsiveness may be caused by the high material density altering the biomechanical signal (increased mechanostat set-point) or by the reduced bone formation capacity typical for OI bone. Given the reduced peak force per muscle area reported in OI children (2), we speculate that the biomechanical bone strain imposed by muscle forces may possibly be translated more slowly in OI bone compared with that of able-bodied children. Although diseasespecific bone material properties may offer an explanation for decreased biomechanical responsiveness of OI bone, the decreased responsiveness of OI muscle function to WBV therapy may also have its origin in defective collagen type 1. Tendons contain plenty of collagen type 1 and transmit forces from muscles to bones. In OI, the Figure 2 . (a) The vibration group (white boxes) had greater increments in total lean mass over 5 months compared with pubertal stage-and sex-matched controls (gray boxes), with similar trends in leg lean mass and cross-sectional muscle area at the proximal tibia (66% site). (b) There were no corresponding differences in total or leg bone mineral content (BMC) or proximal tibia cross-sectional bone area (CSA). Box-plots depict median, interquartile range and 5%/95% percentiles.
biomechanical properties of tendons are impaired (50) , possibly altering transmission of forces and dynamic function. Of note, reduced muscle forces and dynamic function at baseline are not just found in children with OI, but also in the OI mouse model (51) .
Whether and how much an individual can improve his/ her muscle function in response to WBV therapy depends to some extent on the mobility and function of the individual at baseline and the intensity of training. Our cohort did not include children with severe forms of OI, in fact all were at least partially mobile by design. In their observational study of children with more severe OI, Hoyer-Kuhn et al. (25) reported the effect of a rehabilitation concept including WBV, not a direct effect of WBV in isolation. In general, the forces applied during WBV are lower than during walking or running (45) (46) (47) . Although the level of immobility in our cohort was not severe, with habitual loading forces greater than those used during WBV, it is a fact that WBV is used as an effective fitness tool in able-bodied individuals (8) . Therefore, one would still expect positive results even in our patient group with limited mobility.
The intensity and duration of training in the current study (20 to 25 Hz, 3 3 3 minutes, twice daily, for 5 months) was comparable with other WBV studies in children. In fact, most studies in cerebral palsy used a once-daily or five times/ week vibration regimen, for 5 to 6 months. In addition, adherence to WBV was comparable with a recent larger scale WBV study in children (52) . Finally, there are different brands, models, and types (vertical, rotational) of WBV devices available on the market, with variable levels of evidence supporting their effectiveness (53).
This study found that higher BMI z score correlated with higher CHAQ score and lower 6MWD, bodyweight-related peak power, velocity, and jumping height in the two-legged jump at baseline. Such negative associations between overweight and weight-related jumping outcomes have been previously described in able-bodied children (54) . Our results indicate decreased mobility and whole-body muscle performance in overweight children with OI. Because overweight in OI is also associated with higher fracture rates (55), lifestyle modification should be an integral part of OI management (56) .
Limitations of this study include its small sample size. Care was taken not to include patients who had started BP therapy in the last 2 years, which is associated with secondary gains in mobility. The number of patients with previous and current BP therapy happened to be identical in both groups. Although we cannot completely exclude an effect, we consider it unlikely given that the 5-month changes observed in the pair of identical twins was in line with the overall study results.
Conclusion
Although it is possible that treatment response in dynamic muscle function and bone may require longer training durations in children with OI, the effort and engagement required from the child and parents for this training is substantial. Therefore, the lack of a measurable bone effect over 5 months suggests that rotational WBV therapy is not a practical, effective treatment tool to increase bone formation and strength in OI. The incident 
